Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1994 1
1999 1
2000 1
2001 4
2006 1
2010 2
2011 1
2013 1
2014 1
2015 3
2016 1
2017 4
2018 1
2019 6
2020 4
2021 7
2022 6
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Results by year

Filters applied: . Clear all
Page 1
Botulinum toxin as a biological weapon: medical and public health management.
Arnon SS, Schechter R, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Fine AD, Hauer J, Layton M, Lillibridge S, Osterholm MT, O'Toole T, Parker G, Perl TM, Russell PK, Swerdlow DL, Tonat K; Working Group on Civilian Biodefense. Arnon SS, et al. Among authors: fine ad. JAMA. 2001 Feb 28;285(8):1059-70. doi: 10.1001/jama.285.8.1059. JAMA. 2001. PMID: 11209178 Review.
A longitudinal circulating tumor DNA-based model associated with survival in metastatic non-small-cell lung cancer.
Assaf ZJF, Zou W, Fine AD, Socinski MA, Young A, Lipson D, Freidin JF, Kennedy M, Polisecki E, Nishio M, Fabrizio D, Oxnard GR, Cummings C, Rode A, Reck M, Patil NS, Lee M, Shames DS, Schulze K. Assaf ZJF, et al. Among authors: fine ad. Nat Med. 2023 Apr;29(4):859-868. doi: 10.1038/s41591-023-02226-6. Epub 2023 Mar 16. Nat Med. 2023. PMID: 36928816 Free PMC article.
Changes in Circulating Tumor DNA Reflect Clinical Benefit Across Multiple Studies of Patients With Non-Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors.
Vega DM, Nishimura KK, Zariffa N, Thompson JC, Hoering A, Cilento V, Rosenthal A, Anagnostou V, Baden J, Beaver JA, Chaudhuri AA, Chudova D, Fine AD, Fiore J, Hodge R, Hodgson D, Hunkapiller N, Klass DM, Kobie J, Peña C, Pennello G, Peterman N, Philip R, Quinn KJ, Raben D, Rosner GL, Sausen M, Tezcan A, Xia Q, Yi J, Young AG, Stewart MD, Carpenter EL, Aggarwal C, Allen J. Vega DM, et al. Among authors: fine ad. JCO Precis Oncol. 2022 Aug;6:e2100372. doi: 10.1200/PO.21.00372. JCO Precis Oncol. 2022. PMID: 35952319 Free PMC article.
Tularemia as a biological weapon: medical and public health management.
Dennis DT, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Fine AD, Friedlander AM, Hauer J, Layton M, Lillibridge SR, McDade JE, Osterholm MT, O'Toole T, Parker G, Perl TM, Russell PK, Tonat K; Working Group on Civilian Biodefense. Dennis DT, et al. Among authors: fine ad. JAMA. 2001 Jun 6;285(21):2763-73. doi: 10.1001/jama.285.21.2763. JAMA. 2001. PMID: 11386933 Review.
Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.
Inglesby TV, Dennis DT, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Fine AD, Friedlander AM, Hauer J, Koerner JF, Layton M, McDade J, Osterholm MT, O'Toole T, Parker G, Perl TM, Russell PK, Schoch-Spana M, Tonat K. Inglesby TV, et al. Among authors: fine ad. JAMA. 2000 May 3;283(17):2281-90. doi: 10.1001/jama.283.17.2281. JAMA. 2000. PMID: 10807389 Review.
Infectious Disease Hospitalizations, New York City, 2001-2014.
Huang CC, Lucero DE, Lim S, Zhao Y, Arciuolo RJ, Burzynski J, Daskalakis D, Fine AD, Kennedy J, Haberling D, Vora NM. Huang CC, et al. Among authors: fine ad. Public Health Rep. 2020 Sep/Oct;135(5):587-598. doi: 10.1177/0033354920935080. Epub 2020 Jul 20. Public Health Rep. 2020. PMID: 32687737 Free PMC article.
49 results